Ilomedin

Iloprost Trometamol, the active ingredient in Ilomedin, is a prostacyclin analog presented as an intravenous solution for intravenous use. It is employed in the management of pulmonary arterial hypertension, digital ulcers linked to systemic sclerosis, and peripheral arterial disease in adult patients.

GNH USA supplies Ilomedin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution. GNH USA also offers temperature‑controlled logistics to maintain product integrity during shipment.

Ilomedin (iloprost trometamol) acts on the prostacyclin pathway to treat severe vascular disorders.

Pulmonary arterial hypertension: improves exercise capacity and reduces pulmonary vascular resistance. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces new ulcer formation. Peripheral arterial disease: enhances limb perfusion and may alleviate ischemic symptoms.

Ilomedin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate throbbing pain. - Flushing: transient redness of the face or upper body. - Nausea: occasional upset stomach. - Jaw pain: discomfort during chewing. - Hypotension: mild drop in blood pressure during infusion.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring intervention. - Pulmonary edema: fluid accumulation in the lungs. - Bleeding complications: increased risk of hemorrhage. - Anaphylactic reaction: severe allergic response with airway compromise.

Prior to initiating Ilomedin therapy, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor blood pressure: check regularly during and after infusion. - Assess bleeding risk: avoid in patients with active hemorrhage or severe coagulopathy. - Use caution in renal impairment: adjust monitoring and consider dose modification. - Avoid concurrent potent vasodilators: may precipitate profound hypotension. - Pregnancy: safety not established; weigh potential benefits against risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ilomedin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concomitant use with other potent vasodilators: may cause severe hypotension. - Anticoagulants (e.g., warfarin, heparin): increased risk of bleeding. - Epoprostenol or other prostacyclin analogs: additive vasodilatory effect.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance hypotensive response. - Beta‑blockers: can affect hemodynamic stability. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce prostacyclin‑mediated vasodilation.